<DOC>
	<DOCNO>NCT03005080</DOCNO>
	<brief_summary>This study use 22 gene pharmacogenomics panel 30 child persistent Gastroesophageal Reflux Disease ( GERD ) respond therapy .</brief_summary>
	<brief_title>Pharmacogenetic Testing Children With Persistent Gastroesophageal Reflux Disease</brief_title>
	<detailed_description>This study assess clinical utility pharmacogenomics test clinical management child refractory GERD , despite adequate therapy role pharmacogenomics select right acid suppressive therapy base patient 's symptom pharmacogenomics result .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>persistent gastrointestinal symptom ( GI ) suggestive gastro esophageal reflux disease ( GERD ) despite adequate therapy persistent evidence abnormal reflux index ' acid exposure esophageal multichannel pH impedance study despite adequate therapy persistent endoscopic evidence reflux esophageal disease despite adequate therapy child eosinophilic esophagitis diagnosis child esophageal surgical intervention like fundoplication , tracheoespahgeal fistula repair esophageal atresia repair child diseases affect esophagus , like Crohn 's disease food proteininduced enterocolitis syndrome ( FPIES ) Children research authorization chart</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>